Literature DB >> 7721449

Increased hyaluronic acid in the inner renal medulla of obese dogs.

M Alonso-Galicia1, T M Dwyer, G A Herrera, J E Hall.   

Abstract

Dogs placed on a high-fat diet develop obesity and hypertension associated with marked sodium retention that is due to increased tubular reabsorption. Previous studies showed that renal interstitial hydrostatic pressure is elevated in obese dogs compared with lean dogs, and histological studies revealed increases in medullary interstitial cells and expansion of the medullary but not the cortical extracellular matrix. This matrix stained intensively with Alcian Blue at pH 2.6, colloidal iron, and periodic acid-Schiff, suggesting increased glycosaminoglycans. The goal of this study was to quantitate medullary glycosaminoglycan content in obese (n = 8) compared with lean (n = 8) dogs. Measurement of total glycosaminoglycan content, estimated from uronic acid content, and of hyaluronate, the most abundant glycosaminoglycan in canine renal medulla, with an enzyme-linked immunosorbent assay indicated that there were no significant differences in total glycosaminoglycan or hyaluronate contents in the outer medulla of obese dogs compared with those in lean dogs. In contrast, in the inner medulla of obese dogs there was a 140% increase in hyaluronate compared with the content in lean dogs (4.3 +/- 0.5 versus 1.8 +/- 0.2 mg hyaluronate per gram wet tissue, respectively; P < .05); however, total glycosaminoglycan content was not significantly different (6.9 +/- 0.7 versus 6.2 +/- 0.5 mg uronic acid per gram wet tissue) in obese and lean dogs. These results suggest a change in the relative proportion of the glycosaminoglycan species in the inner medulla of obese dogs, with a selective increase in hyaluronate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721449     DOI: 10.1161/01.hyp.25.4.888

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

2.  Myo-inositol oxygenase accentuates renal tubular injury initiated by endoplasmic reticulum stress.

Authors:  Tatsuya Tominaga; Isha Sharma; Yui Fujita; Toshio Doi; Aryana K Wallner; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

Review 3.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 4.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 5.  Obesity, hypertension, and chronic kidney disease.

Authors:  Michael E Hall; Jussara M do Carmo; Alexandre A da Silva; Luis A Juncos; Zhen Wang; John E Hall
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-02-18

Review 6.  Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics.

Authors:  Nam Hoon Kim; Nan Hee Kim
Journal:  Diabetes Metab J       Date:  2022-07-27       Impact factor: 5.893

Review 7.  Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 8.  Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?

Authors:  William P Martin; James White; Francisco J López-Hernández; Neil G Docherty; Carel W le Roux
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-17       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.